Ergoteles LLC Atea Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$3.0 - $4.97 $16,593 - $27,489	-5,531 Reduced 9.87%	50,500 $169,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.17 $243,734 - $345,711	56,031 New	56,031 $269,000
Q2 2021 Aug 12, 2021	SELL	$19.22 - $59.08 $967,957 - $2.98 Million	-50,362 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$41.42 - $88.44 $2.09 Million - $4.45 Million	50,362 New	50,362 $3.11 Million

111

50.9M

7.6K

38.7K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $262M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.